In the final episode of the series, Drs. John Russell & Neil Skolnik explore the cardiovascular effects associated with SGLT2 inhibitors, as well as the clinical implications of their use in treatment of patients with type 2 diabetes.

Includes ADA’s current clinical practice recommendations, the global standard for diabetes care. Access is free online, where important updates are published throughout the year.

Follow us on Twitter; connect with the diabetes research community and share ideas with fellow professionals. Find the newest published articles, latest podcasts, and up-to-date diabetes news.

Detailed information for authors hoping to submit their manuscript to Diabetes Care.